- Home
- ABEO vs ATNI Comparison
ABEO vs ATNI Comparison
Compare ABEO & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- ATNI
- Stock Information
- Founded
- ABEO N/A
- ATNI 1987
- Country
- ABEO United States
- ATNI United States
- Employees
- ABEO N/A
- ATNI N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- ATNI Telecommunications Equipment
- Sector
- ABEO Health Care
- ATNI Telecommunications
- Exchange
- ABEO Nasdaq
- ATNI Nasdaq
- Market Cap
- ABEO 243.9M
- ATNI 240.6M
- IPO Year
- ABEO 1980
- ATNI 1991
- Fundamental
- Price
- ABEO $5.19
- ATNI $15.66
- Analyst Decision
- ABEO Strong Buy
- ATNI Strong Buy
- Analyst Count
- ABEO 3
- ATNI 2
- Target Price
- ABEO $18.00
- ATNI $31.00
- AVG Volume (30 Days)
- ABEO 251.8K
- ATNI 97.7K
- Earning Date
- ABEO 11-14-2024
- ATNI 02-19-2025
- Dividend Yield
- ABEO N/A
- ATNI 6.06%
- EPS Growth
- ABEO N/A
- ATNI N/A
- EPS
- ABEO N/A
- ATNI N/A
- Revenue
- ABEO N/A
- ATNI $747,493,000.00
- Revenue This Year
- ABEO N/A
- ATNI N/A
- Revenue Next Year
- ABEO $15,721.96
- ATNI $1.20
- P/E Ratio
- ABEO N/A
- ATNI N/A
- Revenue Growth
- ABEO 147.52
- ATNI N/A
- 52 Week Low
- ABEO $3.05
- ATNI $14.85
- 52 Week High
- ABEO $9.01
- ATNI $38.96
- Technical
- Relative Strength Index (RSI)
- ABEO 34.35
- ATNI 37.23
- Support Level
- ABEO $5.05
- ATNI $14.90
- Resistance Level
- ABEO $5.66
- ATNI $16.85
- Average True Range (ATR)
- ABEO 0.27
- ATNI 0.77
- MACD
- ABEO -0.06
- ATNI 0.11
- Stochastic Oscillator
- ABEO 13.21
- ATNI 34.91
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise US Telecom and International Telecom. The company earns revenue from its telecommunication services.